PROCEPT BioRobotics Corp PRCT
4 targets with a reported result
Releases of the last 3 yearsThe numbers PRCT said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| Revenue Fiscal 2026 |
Given $410.00M to $430.00M release Nov 4, 2025
Lowered $390.00M to $410.00M release Feb 25, 2026
Kept $390.00M to $410.00M release Apr 29, 2026
Kept $390.00M to $410.00M release Aug 4, 2026
Kept $390.00M to $410.00M release Nov 4, 2026
|
– | Not reported yet | |
The company's wordsIssued fiscal year 2026 total revenue guidance in the range of $410 to $430 million, representing growth of 26% to 32% compared to fiscal 2025 revenue guidance of $325.5 million. release Nov 4, 2025 Considering these factors, together with the short-term disruption associated with the sales force realignment, we are resetting our 2026 guidance to $390 to $410 million, representing annual growth of 27% to 33%. release Feb 25, 2026 The Company continues to expect revenue for the full year 2026 to be in the range of $390 million to $410 million, which represents growth of 27% to 33% compared to the prior year period release Apr 29, 2026 The Company reiterates revenue for the full year 2026 to be in the range of $390 million to $410 million, which represents growth of 27% to 33% compared to the prior year period release Aug 4, 2026 The Company reiterates revenue for the full year 2026 to be in the range of $390 million to $410 million, which represents growth of 27% to 33% compared to the prior year period release Nov 4, 2026 | ||||
| Revenue Q1 of fiscal 2026 |
Given $79.00M to $82.00M release Feb 25, 2026
|
$83.13M 10-Q filed 2026-04-30 |
Above the range | |
The company's wordsTotal revenue for the first quarter of 2026 is expected to be in the range of $79 million to $82 million dollars, which represents growth of 14% to 19% to the prior year period. release Feb 25, 2026 | ||||
| EBITDA (company-defined) Fiscal 2025 (ended Dec 31, 2025) |
Given $35.00M release Feb 25, 2025
|
– | No standard number | |
The company's words2025 Financial Guidance … The Company projects full year 2025 Adjusted EBITDA loss to be approximately $ 35 million release Feb 25, 2025 | ||||
| Revenue Fiscal 2025 (ended Dec 31, 2025) |
Given $320.00M release Feb 25, 2025
Raised $323.00M release Apr 24, 2025
Raised $325.50M release Aug 6, 2025
|
$308.05M 10-K filed 2026-02-26 |
Below the range | |
The company's words2025 Financial Guidance … The Company projects revenue for the full year 2025 to be approximately $320 million, which would represent 42% growth over the Company’s prior year revenue release Feb 25, 2025 Full Year 2025 Financial Guidance … The Company projects revenue for the full year 2025 to be $323.0 million, which represents 44% growth over the Company’s prior year revenue. release Apr 24, 2025 Full Year 2025 Financial Guidance … The Company projects revenue for the full year 2025 revenue to be approximately $325.5 million, which represents 45% growth over the Company’s prior year revenue. release Aug 6, 2025 | ||||
| Revenue Q1 of fiscal 2025 |
Given $65.50M release Feb 25, 2025
|
$69.16M 10-Q filed 2025-05-02 |
Above the range | |
The company's wordsFirst Quarter of 2025 Financial Guidance … The Company projects revenue for the first quarter of 2025 to be approximately $65.5 million release Feb 25, 2025 | ||||
| EBITDA (company-defined) Fiscal 2024 (ended Dec 31, 2024) |
Given $60.00M release Oct 28, 2024
|
– | No standard number | |
The company's wordsIncreased fiscal year 2024 Adjusted EBITDA guidance to a loss of $60.0 million release Oct 28, 2024 | ||||
| Revenue Fiscal 2024 (ended Dec 31, 2024) |
Given $217.00M release Aug 1, 2024
Raised $222.50M to $223.00M release Oct 28, 2024
|
$224.50M 10-K filed 2025-02-27 |
Above the range | |
The company's wordsIncreased fiscal year 2024 total revenue guidance to approximately $217 million and improved EBITDA guidance to a loss of $67.5 million release Aug 1, 2024 Increased fiscal year 2024 total revenue guidance range to $222.5 million to $223.0 million release Oct 28, 2024 | ||||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (11 releases since 2024-08-01), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PRCT/export.csv") into a cell.